Provided by Tiger Fintech (Singapore) Pte. Ltd.

Mind Medicine (MindMed) Inc.

6.15
-0.3100-4.80%
Post-market: 6.160.0110+0.18%19:32 EDT
Volume:946.65K
Turnover:5.86M
Market Cap:464.64M
PE:-3.99
High:6.53
Open:6.46
Low:6.03
Close:6.46
Loading ...

5 Biotech Breakthrough Stocks to Watch in 2025

Zacks
·
23 Dec 2024

Chardan Initiates Coverage on Mind Medicine With Buy Rating, $20 Price Target

MT Newswires Live
·
20 Dec 2024

Mind Medicine initiated with a Buy at Chardan

TIPRANKS
·
20 Dec 2024

Mind Medicine to Join Nasdaq Biotechnology Index

MT Newswires Live
·
19 Dec 2024

Mind Medicine to be added to Nasdaq Biotechnology Index December 23.

TIPRANKS
·
19 Dec 2024

MindMed to Be Added to the Nasdaq Biotechnology Index

Business Wire
·
19 Dec 2024

Mind Medicine Price Target Maintained With a $20.00/Share by Oppenheimer

Dow Jones
·
18 Dec 2024

Mind Medicine (MNMD) Receives a Buy from Oppenheimer

TIPRANKS
·
17 Dec 2024

MindMed Begins Phase 3 LSD Study for Anxiety

TIPRANKS
·
17 Dec 2024

Mind Medicine Doses First Patient in Phase 3 Study of MM120 to Treat Generalized Anxiety Disorder

MT Newswires Live
·
16 Dec 2024

BRIEF-Mindmed Announces First Patient Dosed In Phase 3 Voyage Study Of Mm120 In Generalized Anxiety Disorder (Gad)

Reuters
·
16 Dec 2024

Mind Med: First patient dosed in Voyage study of LSD in treatment of GAD

TIPRANKS
·
16 Dec 2024

Mind Medicine (MindMed) Inc - Topline Data From 12-Week Double-Blind Period Expected in First Half of 2026

THOMSON REUTERS
·
16 Dec 2024

Mind Medicine (MindMed) Inc - Panorama Study to Initiate in U.S. and Europe in First Half of 2025

THOMSON REUTERS
·
16 Dec 2024

MindMed Announces First Patient Dosed in Phase 3 Voyage Study of Mm120 in Generalized Anxiety Disorder (Gad)

THOMSON REUTERS
·
16 Dec 2024

MindMed Announces First Patient Dosed in Phase 3 Voyage Study of MM120 in Generalized Anxiety Disorder (GAD)

Business Wire
·
16 Dec 2024

MindMed Scientific Presentations at American College of Neuropsychopharmacology (ACNP) 2024 Congress

Business Wire
·
11 Dec 2024

Mind Medicine Gets UK's Innovation Passport Designation for Investigational Anxiety Disorder Treatment

MT Newswires Live
·
06 Dec 2024

Mind Medicine awarded innovation passport designation by UK to treat GAD

TIPRANKS
·
05 Dec 2024

Mind Medicine: Awarded Innovation Passport Designation by UK Ilap Steering Group for Mm120 Odt for Generalized Anxiety Disorder

THOMSON REUTERS
·
05 Dec 2024